Results 11 to 20 of about 28,269 (176)

Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination [PDF]

Infectious Diseases and Therapy
In 2022, experts convened under the name Advancing Strategies to Prevent Meningococcal Disease (ARTEMIS) to gather insights on issues related to invasive meningococcal disease (IMD) and meningococcal vaccination in the US. Discussions regarding successes,
Jessica Presa, Ruth Carrico, Jaime E. Fergie, Stephanie Hanenberg, Gary S. Marshall, Kaitlyn Rivard, Jana Shaw, Gregory D. Zimet, Paula Peyrani, Alejandro Cane   +9 more
doaj   +2 more sources

Meningococcal disease

Journal of the Ceylon College of Physicians
Meningococcal disease, caused by Neisseria meningitidis, is a rapidly progressive, potentially life-threatening infection. The organism, an encapsu-lated Gram-negative diplococcus, is classified into at least 13 serogroups, with A, B, C, W, X, and Y being responsible for most invasive cases.
McNamara LA, Rubis AB.
europepmc   +3 more sources

Imaging of disease dynamics during meningococcal sepsis. [PDF]

PLoS ONE, 2007
Neisseria meningitidis is a human pathogen that causes septicemia and meningitis with high mortality. The disease progression is rapid and much remains unknown about the disease process. The understanding of disease development is crucial for development
Hong Sjölinder, Ann-Beth Jonsson
doaj   +1 more source

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study

The Lancet Public Health, 2017
Background: Since 2009, the incidence of meningococcal serogroup W disease has increased rapidly in the UK because of a single strain (the so-called original UK strain) belonging to the hypervirulent sequence type-11 clonal complex (cc11), with a variant
Dr Mirjam J Knol, PhD, Susan J M Hahné, PhD, Jay Lucidarme, PhD, Helen Campbell, MSc, Hester E de Melker, PhD, Stephen J Gray, PhD, Prof Ray Borrow, FRCPath, Shamez N Ladhani, MRCPCH, Mary E Ramsay, FFPHM, Arie van der Ende, PhD   +9 more
doaj   +1 more source

Meningococcal Disease and Related Vaccinations: Knowledge, Attitudes, and Practices among Healthcare Workers Who Provide Care to Patients with Underlying High-Risk Medical Conditions

Vaccines, 2020
This cross-sectional study assessed knowledge, attitudes, and practices regarding meningococcal disease and related vaccinations among healthcare workers (HCWs) who provided care to patients with underlying high-risk medical conditions.
Gabriella Di Giuseppe, Concetta P. Pelullo, Giorgia Della Polla, Maria Pavia   +3 more
doaj   +1 more source

Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab

Emerging Infectious Diseases, 2018
Patients receiving eculizumab have an increased risk for meningococcal disease, but most reported cases are attributable to encapsulated meningococcal strains.
Deirdre Nolfi-Donegan, Monica Konar, Vianca Vianzon, Jessica MacNeil, James Cooper, Perrianne Lurie, Judi Sedivy, Xin Wang, Dan M. Granoff, Lucy McNamara   +9 more
doaj   +1 more source

Preventing invasive meningococcal disease in early infancy

Human Vaccines & Immunotherapeutics, 2022
This review considers the pathogenesis, diagnosis, and epidemiology of invasive meningococcal disease in infants, to examine and critique meningococcal disease prevention in this population through vaccination.
Jessica Presa, Lidia Serra, Catherine Weil-Olivier, Laura York   +3 more
doaj   +1 more source

Population-based study of influenza and invasive meningococcal disease among Greek children during the COVID-19 pandemic

BMJ Paediatrics Open, 2022
Background Aiming to the containment of the coronavirus disease 2019 (COVID-19) pandemic, governments worldwide have implemented a series of non-pharmaceutical interventions.
Theoklis Zaoutis, Vassiliki Papaevangelou, Danai Ktena, Eleni Kourkouni, Flora Kontopidou, Kassiani Gkolfinopoulou, Kalliopi Papadima, Theano Georgakopoulou, Ioanna Magaziotou, Anastasia Andreopoulou, Georgina Tzanakaki   +10 more
doaj   +1 more source

Meningococcal Disease

Neurosciences, 2002
Meningococcal disease occurs as both endemic and epidemic disease in most parts of the world with significant morbidity and mortality. Among the different serogroups of Neisseria meningitidis, serogroups A, B, C account for 90% of the disease. In the last few years there has been a change in the epidemiology of the disease with an increase in the ...
Ziad A, Memish, Abdulrahman A, Alrajhi
openaire   +3 more sources

Meningococcal Disease and Travel [PDF]

Clinical Infectious Diseases, 2002
Invasive meningococcal disease, in both endemic and epidemic forms, is the cause of significant morbidity and mortality worldwide. Despite all advances in therapy, the fatality rate of meningococcal meningitis remains unacceptably high, between 5% and 10%, and a similar proportion suffers long-term neurological sequalae.
openaire   +2 more sources